Cyclerion Therapeutics Inc CYCN
$3.44
▼ -1.71%
($-0.06)
⬇️ Below Yest. Low
🎈 Low Float
📅 Earnings This Week
Open
$3.48
Prev Close
$3.50
Day Range
$3.36 – $3.60
52W Range
$1.03 – $8.48
Market Cap
$16.10M
Beta
1.75
EPS (TTM)
$-1.37
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2019-03-18 |
| Shares Out. | 4,680,000 |
| Website | cyclerion.com/ ↗ |
| Phone | 16176217722 |
| Employees | 1 |
| Net Income | -$3.2M |
| Free Cash Flow | -$3.6M |
| Total Assets | $8.5M |
| Total Liabilities | $1.7M |
| Equity | $6.8M |
About Cyclerion Therapeutics Inc
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. The company focuses on enabling the full therapeutic potential of next-generation sGC stimulators and neuropsychiatric diseases. Its pipeline products include Olinciguat, Praliciguat, and others.
Cyclerion Therapeutics Inc is a publicly traded company under the ticker symbol CYCN on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
7 analysts (2023-05-01)